More than PLN 10 million in funding from the Medical Research Agency will be given to the Medical University of Gdańsk for the creation of the Multidisciplinary Clinical Support Center. It will be one of ten units in the country that will allow for better coordination of clinical trials in Poland. As part of the competition for the creation and development of Clinical Research Support Centers, the Agency received 30 applications for a total amount of over PLN 300 million.
- I am very glad that the Medical University of Gdańsk was among the 10 beneficiaries selected in the competition. This is another success of our University in acquiring projects from the Medical Research Agency. I am convinced that providing comprehensive and systemic support for the implementation of research will translate into an increase in the number of commercial and non-commercial research, which is particularly important for our patients and the development of research at our University – says Prof. Edyta Szurowska, M.D., Ph.D., Vice-Rector for Clinical Affairs of the MUG. – I would like to thank Magdalena Leszczyńska-Wiloch, Pharm. D. acting Head of Office for Clinical Affairs and Piotr Kraszewski, M.A. from the Department of Non-Commercial Clinical Research and Dr. Blanka Seklecka, Ph.D. from the Early Phase Clinical Research Center, Univeristy Clinical Center for preparing this project.
Apart from the MUG, among the beneficiaries there are nine centers: Medical University of Lodz, Medical University of Bialystok, Poznan University of Medical Science, Military Institute of Medicine, Maria Sklodowska-Curie Institute – Oncology Centre (MSCI), branch in Gliwice, Cardinal Stefan Wyszynski Institute of Cardiology, The Children’s Memorial Health Institute, Wroclaw Medical University and the National Geriatrics, Rheumatology and Rehabilitation Institute.
Institutions that receive grants will create a Clinical Research Support Center (pol.) CWBK as a shared service center, providing comprehensive and systemic support for the implementation of both commercial and non-commercial research. This support will include: planning, management, accounting and research coordination. The CWBK infrastructure will include: a space allowing for outpatient visits, a patient relaxation zone, a teleconference room and work rooms for the Sponsor’s representatives.
- Selected units have an excellent staff of professors who have a huge number of patients and often treat extremely difficult cases. I am convinced that, on the one hand, these centers will provide comfort to patients, and on the other hand, they will allow for the development of a very high standard of research, emphasizes Dr. Radosław Sierpiński, M.D., president of the Medical Research Agency.
The CWBK network aims to ensure a joint standard of research implementation, high quality of patient service and increase the number of commercial and non-commercial clinical trials. The establishment of the network will allow the creation of standardized centers similar to the structures existing in Western Europe. They will become flagship healthcare institutions conducting research of the highest standard, with care for the safety of research participants. As a result, clinical trials in Poland will be conducted in a hospital-friendly and patient-friendly environment. The first investments in the beneficiary nstitutions are planned for this year.